Research Confirms Patients with Essential Tremor and Parkinson’s Disease Have Higher Comorbidities and Costs

Posted on May 18, 2022

SAN MATEO, Calif., May 18, 2022–(BUSINESS WIRE)–Cala Health, the bioelectronic medicine leader setting a new standard of patient care for chronic disease, today announced new clinical research presented at ISPOR 2022. The study, titled “Co-Morbidities and Mechanistic Similarities of Essential Tremor and Parkinson’s Disease and Resulting Diagnostic Challenges,” analyzed comorbidities among patients diagnosed with essential tremor and Parkinson’s disease using claims data from Truven Health Analytics MarketScan® Commercial and Medicare Supplemental databases (2013-2019).

One thought on “Research Confirms Patients with Essential Tremor and Parkinson’s Disease Have Higher Comorbidities and Costs

  1. Would there be any chance I could get on a trial for Colo when they have another group. I live in Eugene Oregon and we don’t get a lot of info about trials. Most the doc are auitting. As a matter of fact I just got notice today that I have been dropped from my neurologist. For no reason. The only thing that shakes bad is hands. Thank you.
    Jacalyn Farris
    541 520 6430

Comments are closed.